PSA Screening for HIM Act

S 2821, the PSA Screening for HIM Act, requires group health plans and individual health insurance issuers to cover prostate-specific antigen (PSA) screenings for high-risk men without out-of-pocket costs. It directly affects men aged 40+ who are at high risk due to being African-American or having a family history of prostate cancer (e.g., a father or brother diagnosed with the disease). The bill amends health coverage rules to mandate this specific screening coverage, effective for plan years starting January 1, 2024. This policy change aims to improve early detection rates, which have near 100% survival when caught early, addressing disparities in prostate cancer outcomes.